[Kemenkes, 2015]

[Kemenkes, 2015]

Penggunaan Mobile X-ray

The portable X-ray devices market was valued at USD 3,067.0 million in 2012. The computed
radiography (CR) based portable X-ray devices market held majority of the market share in 2012 at
39.6% with USD 1,214.8 million in 2012. Kelebihan : These devices are more user friendly than
digital radiography systems and so entail minimum re-training of radiologists. This makes the use
of computed radiography systems a cost effective and time saving affair. Moreover, faster image
acquisition rates and the use of cheaper high density line scan solid state detection systems or
phosphor plates used in these systems are some of the drivers of this market.
The portable X-ray devices market was dominated by the mobile X-ray devices market in 2012
on account of factors such as the growing demand for bedside imaging and the growing base of
geriatric population widening the base of immobile patients.

However, its market share will decline by 2020 on account of the rising demand for user friendly
handheld X-ray devices especially in the field of dentistry and the subsequent introduction of
products such as the NOMAD Pro by Aribex.
Data kompetitor
Philips Healthcare dominated the global portable X-ray devices market with a market share of
over 17% in 2012. Philips Healthcare possesses an extensive product portfolio catering to the x-ray
segment ranging from stationary x-ray systems to digital and portable x-ray systems. Moreover, the
introduction of innovative products capitalizing on customer preferences such as the introduction of
Practix 360, which is a portable x-ray machine and is 30% lighter than the conventional portable xray machines, also helps it maintain its market position. Some of the other players of this market
include GE Healthcare, Siemens Healthcare, Hitachi Medical Systems, Varian Medical
Systems, Shimadzu Corporation and others.
Computed Radiography

[http://www.bccresearch.com/pressroom/hlc/global-market-medical-imaging-technology-oncologydiagnostics-worth-$14.8-billion-2015]
For oncology diagnostics